BCM
DMTK

BlueCrest Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

BlueCrest Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,009
Closed -$514K – 422
2020
Q3 		$514K Buy
+43,009
New +$498K 0.02% 239
2019
Q4 		– Sell
-14,146
Closed -$79K – 626
2019
Q3 		$79K Buy
+14,146
New +$169K 0.01% 536

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlueCrest Capital Management's DMTK Position: Q4 2020 in Review

BlueCrest Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2020, closing a stake of 43,009 shares — an estimated $514K sold.

BlueCrest Capital Management first reported a position in DMTK in Q3 2019 and held it in 2 quarters. The position peaked at $514K in Q3 2020. 85 funds tracked by Wall St. Rank hold DMTK as of Q4 2020.

  • BlueCrest Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • BlueCrest Capital Management sold 43,009 DermTech, Inc. Common Stock shares in Q4 2020, an estimated $514K.
  • BlueCrest Capital Management first reported a position in DermTech, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • BlueCrest Capital Management's DermTech, Inc. Common Stock position peaked at $514K in Q3 2020.
  • 85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2020.

Based on BlueCrest Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.